Molecular Cancer Therapeutics

Published by: American Association for Cancer Research  

People

  1. Ladanyi
    Ladanyi
  2. Kris
    Kris
  3. Riely
    Riely
  4. Arcila
    Arcila
  5. Chaft
    Chaft
  6. Paik
    Paik
  7. Rekhtman
    Rekhtman
  8. Rusch
    Rusch
  9. Antonescu
    Antonescu
  10. Aras
    Aras

Groups

  1. Department of Pathology and Laboratory Medicine (17)
  2. GSK Faculty (14)
  3. Human Oncology and Pathogenesis Program (12)
  4. Department of Medicine (10)
  5. Solid Tumor Oncology Division (10)
  6. Tow Center for Developmental Oncology (TCDO) (9)
  7. Sloan Kettering Institute Postdocs (8)
  8. Surgery (7)
  9. Thoracic Oncology (6)
  10. Radiology, Department of (4)
Search Within
  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (5)
Groups
  1. Department of Pathology and Laboratory Medicine (17)
  2. GSK Faculty (14)
  3. Human Oncology and Pathogenesis Program (12)
  4. Department of Medicine (10)
  5. Solid Tumor Oncology Division (10)
  6. Tow Center for Developmental Oncology (TCDO) (9)

More Groups

People
  1. Marc Ladanyi (7)
  2. Gregory Riely (3)
  3. Mark Kris (3)
  4. Romel Somwar (3)
  5. Camelia Sima (2)
  6. Jamie Chaft (2)

More People

Years
  1. 2024 (1)
  2. 2022 (3)
  3. 2019 (3)
  4. 2017 (2)
  5. 2015 (1)
  6. 2013 (1)

More Years

Publishers
  1. American Association for Cancer Research (17)

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MIG6 mediates adaptive and acquired resistance to ALK/ROS1 fusion kinase inhibition through EGFT bypass signaling
    Journal Article

    Chen, N.; Tyler, L. C.; Le, A. T.; Welsh, E. A.; Fang, B.; Elliott, A.; Davies, K. D.; Danhorn, T.; Riely, G. J.; Ladanyi, M.; more...
    Molecular Cancer Therapeutics (2024)

    Fulltext@MSK | Save
  • Resistance profile and structural modeling of next-generation ROS1 tyrosine kinase inhibitors
    Journal Article

    Keddy, C.; Shinde, P.; Jones, K.; Kaech, S.; Somwar, R.; Shinde, U.; Davare, M. A.
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Targeting the mTOR pathway in hurthle cell carcinoma results in potent antitumor activity
    Journal Article

    Dong, Y.; Gong, Y.; Kuo, F.; Makarov, V.; Reznik, E.; Nanjangud, G. J.; Aras, O.; Zhao, H.; Qu, R.; Fagin, J. A.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Intraperitoneal pretargeted radioimmunotherapy for colorectal peritoneal carcinomatosis
    Journal Article

    Chandler, C. S.; Bell, M. M.; Chung, S. K.; Veach, D. R.; Fung, E. K.; Punzalan, B.; Burnes Vargas, D.; Patel, M.; Xu, H.; Guo, H. F.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Clinical proof of concept for MCLA-128, a bispecific HER2/3 antibody therapy, in NRG1 fusion-positive cancers
    Meeting Abstract

    Schram, A. M.; O'Reilly, E. M.; Somwar, R.; Benayed, R.; Shameem, S.; Chauhan, T.; Torrisi, J.; Ford, J.; Maussang, D.; Wasserman, E.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Lower cellular activation of cMET signaling network is associated with reduced recurrence risk in stage II colorectal cancer
    Meeting Abstract

    McDonough, E.; Sood, A.; Ginty, F.; Cho, S.; Graf, J.; Prehn, J.; Dunne, P.; Lindner, A.; Salvucci, M.; Longley, D.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Aberrant expression of ERG promotes resistance to combined PI3K and AR pathway inhibition through maintenance of AR target genes
    Journal Article

    Mao, N.; Gao, D.; Hu, W.; Hieronymus, H.; Wang, S.; Lee, Y. S.; Lee, C.; Choi, D.; Gopalan, A.; Chen, Y.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Overcoming drug resistance to Trk inhibition by rational combination of entrectinib and trametinib: From bench to bedside
    Meeting Abstract

    Wei, G.; Maneval, E. C.; Esquibel, V.; Berger, M. F.; Haque, S.; Patel, R.; Walsh, C.; Hornby, Z.; Multani, P.; Li, G.
    Molecular Cancer Therapeutics (2017)

    Fulltext@MSK | Save
  • Wnt/β-catenin signaling contributes to tumor malignancy and is targetable in gastrointestinal stromal tumor
    Journal Article

    Zeng, S.; Seifert, A. M.; Zhang, J. Q.; Cavnar, M. J.; Kim, T. S.; Balachandran, V. P.; Santamaria-Barria, J. A.; Cohen, N. A.; Beckman, M. J.; Medina, B. D.; more...
    Molecular Cancer Therapeutics (2017)

    Fulltext@MSK | Save
  • Optimizing the sequence of anti-EGFR-targeted therapy in EGFR-mutant lung cancer
    Journal Article

    Meador, C. B.; Jin, H.; de Stanchina, E.; Nebhan, C. A.; Pirazzoli, V.; Wang, L.; Lu, P.; Vuong, H.; Hutchinson, K. E.; Jia, P.; more...
    Molecular Cancer Therapeutics (2015)

    Fulltext@MSK | Save

    • Molecular Cancer Therapeutics – authorized name for:

    Name ISSN / ISBN Publisher
    Molecular Cancer Therapeutics 15388514 American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 15388514 American Association for Cancer Research
    Molecular cancer therapeutics 15388514 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 Unknown
    Molecular Cancer Therapeutics 15357163 The Authors the American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 Unknown
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research